Study summary · research use only
[Immunocorrective effect of cycloferon and thymogen in patients with uterine cancer]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This article describes immunological findings in women diagnosed with hysterocarcinoma (uterine cancer), who the authors report showed pronounced immunological disturbances before surgery that tended to worsen after surgical intervention. They report that use of cycloferon (cyclopheronum) and thymogen was associated with normalization of immune-status values, accompanied clinically by a more favourable postoperative course. The abstract is brief and describes the findings without quantitative data.
Abstract
Those women diagnosed as having hysterocarcinoma demonstrate even before surgery pronounced immunological disturbances tending to progress after surgical intervention. The employment of cyclopheronum and thymogenum makes for normalization of values for the immune status. Clinically, this is accompanied by a more favourable postoperative course.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.